Phase Ib multiple-dose trial of brilacidin [PMX 30063] in volunteers.

Trial Profile

Phase Ib multiple-dose trial of brilacidin [PMX 30063] in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Jun 2017

At a glance

  • Drugs Brilacidin (Primary)
  • Indications Staphylococcal infections
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 05 Jun 2017 Results presented at the ASM Microbe 2017
    • 10 May 2011 Results presented at the 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy.
    • 31 Mar 2010 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top